FDA Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) 23rd Meeting, August 1, 2011
Gaithersburg, MD
Issue Summary
Donor Deferral/Ineligibility for Time Spent in Saudi Arabia to Reduce Risk of vCJD Transmitted by Blood and Blood Products and by Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps)
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/TransmissibleSpongiformEncephalopathiesAdvisoryCommittee/UCM265682.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/TransmissibleSpongiformEncephalopathiesAdvisoryCommittee/UCM265683.pdf
full-text ►
UCM265682.pdf: "- Enviado mediante la barra Google"
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario